PABLO DE LA
CUEVA DOBAO
Profesor asociado de Ciencias de la Salud
Hospital Universitario Virgen Macarena
Sevilla, EspañaHospital Universitario Virgen Macarena -ko ikertzaileekin lankidetzan egindako argitalpenak (22)
2024
-
Approach to the Epidemiology, Disease Management, and Current Challenges in the Management of Generalized Pustular Psoriasis Through a Survey Conducted Among Spanish Dermatologists
Actas Dermo-Sifiliograficas, Vol. 115, Núm. 5, pp. 449-457
-
Consensus Statement from the Spanish Academy of Dermatology and Venereology (AEDV) Psoriasis Working Group (SWG) and Pediatric Working Group (PWG) on the Management of Pediatric Psoriasis
Actas Dermo-Sifiliograficas
2023
-
Selection of Quality Indicators for the Certification of Dermato-Oncology Units: The CUDERMA Project Delphi Consensus Study
Actas Dermo-Sifiliograficas, Vol. 114, Núm. 7, pp. 587-605
-
Treatment of severe atopic dermatitis with tralokinumab in clinical practice: short-term effectiveness and safety results
Clinical and experimental dermatology, Vol. 48, Núm. 9, pp. 991-997
2022
-
Dermatology Care in Spanish Public Hospitals: A Mapping Study of Health Care Resources and Medical and Surgical Activity in Dermatology Departments in 2019
Actas Dermo-Sifiliograficas, Vol. 113, Núm. 5, pp. 467-480
-
Practical Update of the Guidelines Published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPs) on the Treatment of Psoriasis With Biologic Agents: Part 2 — Management of Special Populations, Patients With Comorbid Conditions, and Risk
Actas Dermo-Sifiliograficas, Vol. 113, Núm. 6, pp. 583-609
-
[Translated article] Implementation of Recommendations for the Management of Psoriasis During Preconception, Pregnancy, Postpartum, Breastfeeding, and Perinatal Care
Actas Dermo-Sifiliograficas, Vol. 113, Núm. 7, pp. T666-T673
2021
-
Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study
European Journal of Clinical Nutrition, Vol. 75, Núm. 9, pp. 1368-1382
-
Practical update of the Recommendations Published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPS) on the Treatment of Psoriasis with Biologic Therapy. Part 1. Concepts and General Management of Psoriasis with Biologic Therapy
Actas Dermo-Sifiliograficas
2020
-
Managing Psoriasis Consultations During the COVID-19 Pandemic: Recommendations From the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (AEDV)
Actas Dermo-Sifiliograficas, Vol. 111, Núm. 9, pp. 802-804
2019
-
Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis
Annals of the Rheumatic Diseases, Vol. 78, Núm. 3, pp. 355-364
2018
-
Redefining the therapeutic objective in psoriatic patients candidates for biological therapy
Journal of Dermatological Treatment, Vol. 29, Núm. 4, pp. 334-346
2017
-
Fiabilidad de una aplicación de ayuda a la toma de decisiones terapéuticas en el paciente con psoriasis (MDi Psoriasis®)
Actas Dermo-Sifiliograficas, Vol. 108, Núm. 7, pp. 650-656
-
Psoriasis moderada. Propuesta de definición
Actas Dermo-Sifiliograficas, Vol. 108, Núm. 10, pp. 911-917
-
Reliability of the MDi Psoriasis® Application to Aid Therapeutic Decision-Making in Psoriasis
Actas Dermo-Sifiliograficas, Vol. 108, Núm. 7, pp. 650-656
2016
-
Análisis de coste-efectividad y coste-utilidad de ingenol mebutato versus diclofenaco 3% e imiquimod 5% en el tratamiento de la queratosis actínica en España
Actas Dermo-Sifiliograficas, Vol. 107, Núm. 6, pp. 498-508
-
Genome-Wide Pathway Analysis Identifies Genetic Pathways Associated with Psoriasis
Journal of Investigative Dermatology, Vol. 136, Núm. 3, pp. 593-602
-
Methotrexate in Moderate to Severe Psoriasis: Review of the Literature and Expert Recommendations
Actas Dermo-Sifiliograficas, Vol. 107, Núm. 3, pp. 194-206
-
Methotrexate in Moderate to Severe Psoriasis: Review of the Literature and Expert Recommendations
Actas dermo-sifiliograficas, Vol. 107, Núm. 3, pp. 194-206
-
Urine metabolome profiling of immune-mediated inflammatory diseases
BMC Medicine, Vol. 14, Núm. 1